Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Natalia Luque‐Caro"'
Autor:
Carmen González‐Olmedo, Francisco José García‐Verdejo, Antonio Reguera‐Teba, Carmen Rosa‐Garrido, José Antonio López‐López, Leticia Díaz‐Beltrán, Patricia Mena García, Natalia Luque‐Caro, Fernando Gálvez‐Montosa, Ana Laura Ortega‐Granados, María Ruiz‐Sanjuan, Antonio Cózar‐Ibáñez, Juan Sainz, Juan Antonio Marchal, José Camacho, José Pérez delPalacio, Rosario Fernández‐Godino, Caridad Díaz, Pedro Sánchez‐Rovira
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/7b4ca450c8c744ecbc50aea1cb5911cf
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer
Autor:
Leticia Díaz-Beltrán, Carmen González-Olmedo, Natalia Luque-Caro, Caridad Díaz, Ariadna Martín-Blázquez, Mónica Fernández-Navarro, Ana Laura Ortega-Granados, Fernando Gálvez-Montosa, Francisca Vicente, José Pérez del Palacio, Pedro Sánchez-Rovira
Publikováno v:
Cancers, Vol 13, Iss 1, p 147 (2021)
Purpose: The aim of this study is to identify differential metabolomic signatures in plasma samples of distinct subtypes of breast cancer patients that could be used in clinical practice as diagnostic biomarkers for these molecular phenotypes and to
Externí odkaz:
https://doaj.org/article/ede90584cb8a4f619de82ab399a57401
Publikováno v:
Journal of Gastrointestinal Oncology. 14:692-704
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer
Autor:
Ariadna Martín-Blázquez, José Pérez del Palacio, Leticia Díaz-Beltrán, Pedro Sánchez-Rovira, Fernando Gálvez-Montosa, Mónica Fernández-Navarro, Carmen González-Olmedo, Ana Laura Ortega-Granados, Natalia Luque-Caro, Caridad Díaz, Francisca Vicente
Publikováno v:
Cancers, Vol 13, Iss 147, p 147 (2021)
Cancers
Volume 13
Issue 1
Cancers
Volume 13
Issue 1
Purpose: The aim of this study is to identify differential metabolomic signatures in plasma samples of distinct subtypes of breast cancer patients that could be used in clinical practice as diagnostic biomarkers for these molecular phenotypes and to
Autor:
Pedro Sánchez-Rovira, Carmen Herrero-Rodríguez, Leticia Díaz-Beltrán, Celia Lacárcel-Bautista, María Ángeles Duro-Fernández, Manuel Ruiz-Bailén, Juan Francisco Marín-Pozo, Ana Laura Ortega Granados, Luis Yaguez-Mateos, Gaspar Jesús Duro-Ruiz, Javier García-Alegría, Gerardo Pérez-Chica, Francisco García-Verdejo, Maria Isabel Sierra-Torres, Mónica Fernández-Navarro, Josefa A. Aguilar-García, Natalia Luque-Caro, Agustín Rodríguez-Sánchez, Fernando Gálvez-Montosa, Cristina Quero-Blanco
Publikováno v:
SSRN Electronic Journal.
Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, keeps spreading globally. Evidence suggests that a subgroup of patients with severe symptomatology might have cytokine storms, wh
Autor:
A. García-Palomo, Pedro Sánchez Rovira, Ana Lopez-Gonzalez, Maria del Mar Muñoz Sánchez, Natalia Luque Caro, María José Molina Garrido, Maria del Carmen Soriano Rodríguez, Maria Yéssica Plata Fernández, Laura López-González
Publikováno v:
Future Oncology. 14:5-12
Numerous patient- and disease-related factors must be considered when deciding a treatment approach for hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer. Hormone therapy (HT) is
Autor:
Leticia Díaz-Beltrán, Manuel Ruiz-Bailén, Luis Yaguez-Mateos, María Ángeles Duro-Fernández, Pedro Sánchez-Rovira, Mónica Fernández-Navarro, Ana Laura Ortega-Granados, Juan Francisco Marín-Pozo, Carmen Herrero-Rodríguez, J. García-Alegría, Josefa A. Aguilar-García, Francisco García-Verdejo, Natalia Luque-Caro, Gerardo Pérez-Chica, Celia Lacárcel-Bautista, Fernando Gálvez-Montosa, Cristina Quero-Blanco, Agustín Rodríguez-Sánchez, Maria Isabel Sierra-Torres, Gaspar Jesús Duro-Ruiz
Publikováno v:
Medicine
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, keeps spreading globally. Evidence suggests that a subgroup of patients with severe symptomatology might have cytokine storms, which increase
Autor:
Natalia Luque Caro, David Fernández Garay, Complejo Hospitalario de Jaén, Fernando Gálvez Montosa
Publikováno v:
ACTUALIDAD MEDICA. 102:180-182
Autor:
Maria Del, Mar Muñoz Sánchez, Maria Del, Carmen Soriano Rodríguez, Maria José, Molina Garrido, Ana, López-González, Andrés, García-Palomo, Laura, López-González, Maria Yéssica, Plata Fernández, Natalia Luque, Caro, Pedro Sánchez, Rovira
Publikováno v:
Future oncology (London, England). 14(7s)
Numerous patient- and disease-related factors must be considered when deciding a treatment approach for hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Hormone therapy (HT) is ge
Autor:
Miguel Angel Moreno Jimenez, Mónica Fernández Navarro, Carmen Garrido, Ana Laura Ortega Granados, Juan Francisco Marín Pozo, Nuria Cárdenas Quesada, Pedro Sánchez Rovira, Francisco José García Verdejo, Natalia Luque Caro, Capilla de la Torre Cabrera, María Ruiz Sanjuan
Publikováno v:
Journal of Thoracic Oncology. 12:S917-S918